Kavaliunas A, et al. Impact of early treatment initiation on personal income of multiple sclerosis patients. ECTRIMS 218, abstract 145.
Extra voordeel langere dosisinterval natalizumab: minder JCV-conversie
mei 2025 | Multipele Sclerose
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen